| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.967 | 49.160 | - | 46.782 | - | 34.659 | 34.991 | 19.130 | - | 21.106 |
| Total Income - EUR | 55.967 | 49.165 | - | 46.782 | - | 34.659 | 35.000 | 19.130 | - | 21.106 |
| Total Expenses - EUR | 60.620 | 58.183 | - | 62.384 | - | 47.897 | 40.683 | 22.636 | - | 67.600 |
| Gross Profit/Loss - EUR | -4.653 | -9.018 | - | -15.601 | - | -13.238 | -5.683 | -3.505 | - | -46.493 |
| Net Profit/Loss - EUR | -6.332 | -9.510 | - | -16.063 | - | -13.585 | -6.033 | -3.697 | - | -47.820 |
| Employees | 6 | 7 | - | 5 | - | 3 | 1 | 1 | - | 1 |
Check the financial reports for the company - Tavimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.873 | 12.742 | - | 12.297 | - | 9.645 | 8.164 | 8.189 | - | 8.119 |
| Current Assets | 76.005 | 77.951 | - | 92.123 | - | 76.656 | 69.637 | 74.282 | - | 22.818 |
| Inventories | 72.019 | 74.654 | - | 87.630 | - | 73.371 | 65.817 | 70.311 | - | 14.562 |
| Receivables | 2.629 | 2.378 | - | 2.347 | - | 2.258 | 2.208 | 2.626 | - | 4.459 |
| Cash | 1.357 | 919 | - | 2.145 | - | 1.027 | 1.612 | 1.346 | - | 3.797 |
| Shareholders Funds | -78.276 | -86.988 | - | -114.717 | - | -141.369 | -144.267 | -148.411 | - | -199.119 |
| Social Capital | 45 | 45 | - | 43 | - | 41 | 40 | 41 | - | 40 |
| Debts | 167.154 | 177.681 | - | 219.137 | - | 227.670 | 222.067 | 230.882 | - | 230.056 |
| Income in Advance | 0 | 0 | - | 0 | - | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Tavimed Srl